ArticleACS medicinal chemistry letters2024

Novel Fused Triazole Compounds as RIPK1 Inhibitors for Treating Neurodegenerative, Autoimmune, and Inflammatory Diseases.

Ram W SabnisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.